Previous bioinformatics analysis of TMPRSS2 expression profiles in 32 different tumor tissues has indicated that TMPRSS2 is significantly upregulated in six cancer tissues, including prostate adenocarcinoma (PRAD), and significantly downregulated in six cancer tissues compared to corresponding normal tissues [20]. This evidence concerns the gene TMPRSS2 and neoplasm.